Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INSMED (INSM) EBITDA: 2010-2014

Historic EBITDA for INSMED (INSM) over the last 3 years, with Jun 2014 value amounting to -$23.2 million.

  • INSMED's EBITDA fell 162.30% to -$23.2 million in Q2 2014 from the same period last year, while for Jun 2014 it was -$70.0 million, marking a year-over-year decrease of 67.09%. This contributed to the annual value of -$55.0 million for FY2013, which is 29.64% down from last year.
  • Per INSMED's latest filing, its EBITDA stood at -$23.2 million for Q2 2014, which was down 62.43% from -$14.3 million recorded in Q1 2014.
  • Over the past 5 years, INSMED's EBITDA peaked at $1.8 million during Q4 2010, and registered a low of -$23.2 million during Q2 2014.
  • Its 3-year average for EBITDA is -$13.2 million, with a median of -$13.7 million in 2013.
  • As far as peak fluctuations go, INSMED's EBITDA grew by 11.31% in 2013, and later plummeted by 162.30% in 2014.
  • Quarterly analysis of 4 years shows INSMED's EBITDA stood at $1.8 million in 2010, then reached -$9.4 million in 2012, then crashed by 80.07% to -$15.6 million in 2013, then crashed by 162.30% to -$23.2 million in 2014.
  • Its EBITDA stands at -$23.2 million for Q2 2014, versus -$14.3 million for Q1 2014 and -$15.6 million for Q4 2013.